It s Whacko Wednesday: Two more asinine chemical scares

By ACSH Staff — Apr 09, 2014
At ACSH we shout a lot. Sometimes even at each other. But most of the time it takes the form of shoutouts to like-minded writers and websites (and there aren t

At ACSH we shout a lot. Sometimes even at each other. But most of the time it takes the form of shoutouts to like-minded writers and websites (and there aren t

Taking an NSAID pain killer linked to risk of atrial fibrillation

By ACSH Staff — Apr 09, 2014
A new review shows a link between consumption of an NSAID pain reliever and the arrhythmia, atrial fibrillation. Is it real, that is, causal? Stay tuned, it s not impossible.

A new review shows a link between consumption of an NSAID pain reliever and the arrhythmia, atrial fibrillation. Is it real, that is, causal? Stay tuned, it s not impossible.

Eating disorders are not only a woman s disorder

By ACSH Staff — Apr 09, 2014
Eating disorders are often construed as a woman s issue. Today, however, about 10 to 15 percent of those with eating disorders

Eating disorders are often construed as a woman s issue. Today, however, about 10 to 15 percent of those with eating disorders

Health News Update: April 8, 2014

By ACSH Staff — Apr 08, 2014
Top stories: Mammography guidelines questioned, so-called pediatricians jumping on anti-vaccine bandwagon, and the sour news on Vitamin D, again.

Top stories: Mammography guidelines questioned, so-called pediatricians jumping on anti-vaccine bandwagon, and the sour news on Vitamin D, again.

Anti-vaccination movement allowing old infections to resurface

By ACSH Staff — Apr 08, 2014
Measles is a highly contagious viral infection that once burdened an average 53,000 people in the United States. As of 2000, officials

Measles is a highly contagious viral infection that once burdened an average 53,000 people in the United States. As of 2000, officials

How to mend a broken heart? Attention must be paid to the survivor

By ACSH Staff — Apr 08, 2014
Can you die of a broken heart? A new report says maybe so. Among a group of people who had recently lost a loved one, cardiovascular events increased significantly over the following month.

Can you die of a broken heart? A new report says maybe so. Among a group of people who had recently lost a loved one, cardiovascular events increased significantly over the following month.

Extensive review finds vitamin D no panacea

By ACSH Staff — Apr 08, 2014
Vitamin D, long known to prevent rickets the softening and weakening of bones in children and widely added to milk for that purpose, has been touted in many venues as the latest miracle vitamin.

Vitamin D, long known to prevent rickets the softening and weakening of bones in children and widely added to milk for that purpose, has been touted in many venues as the latest miracle vitamin.

Viagra and melanoma correlation: Is it real?

By ACSH Staff — Apr 08, 2014
In the one more thing to worry about category comes a surprise from a multi-center study just published in JAMA, which postulates that the use of sildenafil (Viagra) may increase the risk of malignant melanoma.

In the one more thing to worry about category comes a surprise from a multi-center study just published in JAMA, which postulates that the use of sildenafil (Viagra) may increase the risk of malignant melanoma.

O, Canada: Why stand in the way of e-cigarettes, harming smokers?

By Gil Ross — Apr 07, 2014
Canadian tobacco expert weighs in on the hypothetical risks and vast potential benefits of e-cigarettes with the goal of spreading sound science information and evidence about e-cigarettes. Canada could certainly use the help.

Canadian tobacco expert weighs in on the hypothetical risks and vast potential benefits of e-cigarettes with the goal of spreading sound science information and evidence about e-cigarettes. Canada could certainly use the help.

Hopeful, but preliminary, results of breast cancer treatment

By ACSH Staff — Apr 07, 2014
A new Pfizer-developed anti-cancer drug the first member of a new class of oncology drugs provided a longer progression-free period compared to the control group. Women with advanced

A new Pfizer-developed anti-cancer drug the first member of a new class of oncology drugs provided a longer progression-free period compared to the control group. Women with advanced